SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-020244
Filing Date
2021-08-16
Accepted
2021-08-16 17:04:19
Documents
47
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 635872
2 ex31-1.htm EX-31.1 13016
3 ex32-1.htm EX-32.1 7620
  Complete submission text file 0001493152-21-020244.txt   3311187

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE lung-20210630.xsd EX-101.SCH 31821
5 XBRL CALCULATION FILE lung-20210630_cal.xml EX-101.CAL 37460
6 XBRL DEFINITION FILE lung-20210630_def.xml EX-101.DEF 113079
7 XBRL LABEL FILE lung-20210630_lab.xml EX-101.LAB 277512
8 XBRL PRESENTATION FILE lung-20210630_pre.xml EX-101.PRE 202288
9 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 378865
Mailing Address 350 W. 800 N. SUITE 214 SALT LAKE CITY UT 84103
Business Address 350 W. 800 N. SUITE 214 SALT LAKE CITY UT 84103 (801) 736-0729
PROLUNG INC (Filer) CIK: 0001541884 (see all company filings)

IRS No.: 201922768 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38362 | Film No.: 211179568
SIC: 3841 Surgical & Medical Instruments & Apparatus
Office of Life Sciences